A Universal Plug-and-Display Vaccine Carrier Based on HBsAg VLP to Maximize Effective Antibody Response

29619211World Malaria Report 20182018

Global Technical Strategy for Malaria 2016–20302015

31094679A Framework for Malaria Elimination2017

Nikolaeva, 2015, Toward the development of effective transmission-blocking vaccines for malaria, Expert Rev Vaccines., 14, 653, 10.1586/14760584.2015.993383

Kaslow, 1988, A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains, Nature., 333, 74, 10.1038/333074a0

Wu, 2008, Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51, PLoS ONE., 3, e2636, 10.1371/journal.pone.0002636

Mohsen, 2017, Major findings and recent advances in virus-like particle (VLP)-based vaccines, Semin Immunol., 34, 123, 10.1016/j.smim.2017.08.014

Manolova, 2008, Nanoparticles target distinct dendritic cell populations according to their size, Eur J Immunol., 38, 1404, 10.1002/eji.200737984

Cubas, 2009, Virus-like particle (VLP) lymphatic trafficking and immune response generation after immunization by different routes, J Immunother., 32, 118, 10.1097/CJI.0b013e31818f13c4

Bachmann, 1993, The influence of antigen organization on B cell responsiveness, Science., 262, 1448, 10.1126/science.8248784

Meireles, 2015, Three decades of hepatitis B control with vaccination, World J Hepatol., 7, 2127, 10.4254/wjh.v7.i18.2127

Harper, 2017, HPV vaccines - a review of the first decade, Gynecol Oncol., 146, 196, 10.1016/j.ygyno.2017.04.004

Kushnir, 2012, Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development, Vaccine., 31, 58, 10.1016/j.vaccine.2012.10.083

Brune, 2018, New routes and opportunities for modular construction of particulate vaccines: stick, click, and glue, Front Immunol., 9, 1432, 10.3389/fimmu.2018.01432

Veggiani, 2014, Superglue from bacteria: unbreakable bridges for protein nanotechnology, Trends Biotechnol., 32, 506, 10.1016/j.tibtech.2014.08.001

Tan, 2016, Kinetic controlled tag-catcher interactions for directed covalent protein assembly, PLoS ONE., 11, e0165074, 10.1371/journal.pone.0165074

Bonnet, 2017, Autocatalytic association of proteins by covalent bond formation: a Bio Molecular Welding toolbox derived from a bacterial adhesin, Sci Rep., 7, 43564, 10.1038/srep43564

Zakeri, 2012, Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin, Proc Natl Acad Sci USA., 109, E690, 10.1073/pnas.1115485109

Veggiani, 2016, Programmable polyproteams built using twin peptide superglues, Proc Natl Acad Sci USA., 113, 1202, 10.1073/pnas.1519214113

Brune, 2016, Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization, Sci Rep., 6, 19234, 10.1038/srep19234

Bruun, 2018, Engineering a rugged nanoscaffold to enhance plug-and-display vaccination, ACS Nano., 12, 8855, 10.1021/acsnano.8b02805

Escolano, 2019, Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques, Nature., 570, 468, 10.1038/s41586-019-1250-z

Leneghan, 2017, Nanoassembly routes stimulate conflicting antibody quantity and quality for transmission-blocking malaria vaccines, Sci Rep., 7, 3811, 10.1038/s41598-017-03798-3

Tissot, 2010, Versatile virus-like particle carrier for epitope based vaccines, PLoS ONE., 5, e9809, 10.1371/journal.pone.0009809

Pastori, 2012, Virus like particle based strategy to elicit HIV-protective antibodies to the alpha-helic regions of gp41, Virology., 431, 1, 10.1016/j.virol.2012.05.005

Cielens, 2014, Mosaic RNA phage VLPs carrying domain III of the West Nile virus E protein, Mol Biotechnol., 56, 459, 10.1007/s12033-014-9743-3

Palladini, 2018, Virus-like particle display of HER2 induces potent anti-cancer responses, Oncoimmunology., 7, e1408749, 10.1080/2162402X.2017.1408749

Govasli, 2019, Virus-like particle-display of the enterotoxigenic Escherichia coli heat-stable toxoid STh-A14T elicits neutralizing antibodies in mice, Vaccine., 37, 6405, 10.1016/j.vaccine.2019.09.004

Janitzek, 2019, A proof-of-concept study for the design of a VLP-based combinatorial HPV and placental malaria vaccine, Sci Rep., 9, 5260, 10.1038/s41598-019-41522-5

2015, First Malaria Vaccine Receives Positive Scientific Opinion From EMA

RTS, 2015, Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial, Lancet., 386, 31, 10.1016/S0140-6736(15)60721-8

Jegerlehner, 2010, Carrier induced epitopic suppression of antibody responses induced by virus-like particles is a dynamic phenomenon caused by carrier-specific antibodies, Vaccine., 28, 5503, 10.1016/j.vaccine.2010.02.103

McCluskie, 2016, The effect of preexisting anti-carrier immunity on subsequent responses to CRM197 or Qb-VLP conjugate vaccines, Immunopharmacol Immunotoxicol., 38, 184, 10.3109/08923973.2016.1165246

De Filette, 2008, Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies, Vaccine., 26, 6503, 10.1016/j.vaccine.2008.09.038

Rehermann, 2005, Immunology of hepatitis B virus and hepatitis C virus infection, Nat Rev Immunol., 5, 215, 10.1038/nri1573

Global Hepatits Report.2017

Ginzberg, 2018, Global HBV burden: guesstimates and facts, Hepatol Int., 12, 315, 10.1007/s12072-018-9884-8

Gallagher, 2017, Characterization of the disassembly and reassembly of the HBV glycoprotein surface antigen, a pliable nanoparticle vaccine platform, Virology., 502, 176, 10.1016/j.virol.2016.12.025

Valea, 2018, Immune response to the hepatitis B antigen in the RTS,S/AS01 malaria vaccine, and co-administration with pneumococcal conjugate and rotavirus vaccines in African children: a randomized controlled trial, Hum Vaccin Immunother., 14, 1489, 10.1080/21645515.2018.1442996

Collins, 2017, Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine, Sci Rep., 7, 46621, 10.1038/srep46621

Chan, 2019, Malaria vaccine candidates displayed on novel virus-like particles are immunogenic and induce transmission-blocking activity, PLoS ONE., 14, e0221733, 10.1371/journal.pone.0221733

Scally, 2017, Molecular definition of multiple sites of antibody inhibition of malaria transmission-blocking vaccine antigen Pfs25, Nat Commun., 8, 1568, 10.1038/s41467-017-01924-3

Kundu, 2018, Structural delineation of potent transmission-blocking epitope I on malaria antigen Pfs48/45, Nat Commun., 9, 4458, 10.1038/s41467-018-06742-9

Lennartz, 2018, Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibody, Nat Commun., 9, 3822, 10.1038/s41467-018-06340-9

Poovorawan, 2010, Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand, Vaccine., 28, 730, 10.1016/j.vaccine.2009.10.074

Poovorawan, 2013, Long-term anti-HBs antibody persistence following infant vaccination against hepatitis B and evaluation of anamnestic response: a 20-year follow-up study in Thailand, Hum Vaccin Immunother., 9, 1679, 10.4161/hv.24844

Stefanati, 2019, Long-term persistency of hepatitis B immunity: an observational cross-sectional study on medical students and resident doctors, J Prev Med Hyg., 60, E184, 10.15167/2421-4248/jpmh2019.60.3.1315

Tfifha, 2019, Evaluation of antibody persistence after a four-dose primary hepatitis B vaccination and anamnestic immune response in children under 6 years, J Med Microbiol., 68, 1686, 10.1099/jmm.0.001086

Van Damme, 2019, Persistence of HBsAg-specific antibodies and immune memory two to three decades after hepatitis B vaccination in adults, J Viral Hepat., 26, 1066, 10.1111/jvh.13125

Ubillos, 2018, Baseline exposure, antibody subclass, and hepatitis B response differentially affect malaria protective immunity following RTS,S/AS01E vaccination in African children, BMC Med., 16, 197, 10.1186/s12916-018-1186-4

Kurtovic, 2019, Induction and decay of functional complement-fixing antibodies by the RTS,S malaria vaccine in children, and a negative impact of malaria exposure, BMC Med., 17, 45, 10.1186/s12916-019-1277-x

Li, 2016, Enhancing immunogenicity and transmission-blocking activity of malaria vaccines by fusing Pfs25 to IMX313 multimerization technology, Sci Rep., 6, 18848, 10.1038/srep18848

Miura, 2013, Qualification of standard membrane-feeding assay with Plasmodium falciparum malaria and potential improvements for future assays, PLoS ONE., 8, e57909, 10.1371/journal.pone.0057909

Miura, 2016, Transmission-blocking activity is determined by transmission-reducing activity and number of control oocysts in Plasmodium falciparum standard membrane-feeding assay, Vaccine., 34, 4145, 10.1016/j.vaccine.2016.06.066